mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
Ko-143 |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.5 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.5 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.5 |
mRNA |
THZ-2-49 |
GDSC1000 |
pan-cancer |
AAC |
-0.02 |
0.5 |
mRNA |
ATRA |
GDSC1000 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
PIK-93 |
GDSC1000 |
pan-cancer |
AAC |
0.019 |
0.5 |